About Saturn Formulations
Saturn Formulations is a company based in Mumbai (India) founded in 2017. It operates as a B2B. Saturn Formulations offers products and services including Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and Abivoclin 2.5%.
- Headquarter Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website saturnformulations.in
- Social Facebook Instagram YouTube
- Legal Name Saturn Formulations Private Limited
- Date of Incorporation 04 Oct, 2013
- Jurisdiction Chandigarh, India
- Annual Revenue₹10.09 Cr
FY 2024 · +10% YoY
- Net Profit₹18.1 Lakh
FY 2024 · 2% margin
- EBITDA₹29.1 Lakh
FY 2024 · 3% margin
Associated legal entities of Saturn Formulations
Saturn Formulations operates through Saturn Formulations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saturn Formulations Private Limited CIN U24232CH2013PTC034756 | Active | 04 Oct 2013 | Chandigarh, Chandigarh | ₹10.1 Cr | – | 2 | View details |
Products & Services of Saturn Formulations
Saturn Formulations offers a comprehensive portfolio of products and services, including Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and Abivoclin 2.5%.
Eye drops containing polyethylene glycol for lubrication and eye protection.
Vitamin D3 oral solution to address nutritional deficiencies.
Meropenem avibactam injection for treating bacterial infections.
Empagliflozin tablet for managing diabetes and related conditions.
Clindamycin and benzoyl peroxide gel for skin infection treatment.
Powder with dextrose and vitamins for energy and health support.
Apps and channels of Saturn Formulations
its YouTube channel Plenum & Saturn has 291 subscribers and 19 videos.
Videos from Saturn Formulations
The most watched videos on Saturn Formulations's YouTube channel, Plenum & Saturn (291 subscribers). Click a video to play it here.
More on Plenum & Saturn .
Board of directors of Saturn Formulations Private Limited (Saturn Formulations)
Saturn Formulations Private Limited is the primary company behind Saturn Formulations. The board of Saturn Formulations Private Limited currently have 2 directors; the longest-serving is Neeraj Sharda, appointed in 2013. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Neeraj Sharda DIN 05236711 | Director | 04 Oct 2013 | 13 yrs | Saturn Formulations Private Limited |
| Hans Raj Sharda DIN 08099490 | Director | 26 Mar 2018 | 8 yrs 6 mo | Saturn Formulations Private Limited |
Financials of Saturn Formulations
Figures of Saturn Formulations Private Limited, the primary company behind Saturn Formulations, for FY 2024. Revenue was ₹10.09 Cr (+10% year on year). Net profit was ₹18.1 Lakh (2% margin). EBITDA was ₹29.1 Lakh (3% margin). Revenue has grown at a compounded annual rate of +32% over three years and +46% over five years.
- ₹10.09 CrRevenue · FY 2024 · +10% YoY
- ₹18.1 LakhNet profit · 2% margin
- ₹29.1 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- +32%Revenue CAGR, 3 years
- +46%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saturn Formulations Private Limited are on its company page.
Detailed financial statements for Saturn Formulations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Saturn Formulations
The website of Saturn Formulations (saturnformulations.in) receives about 13.7K visits a month.
- Monthly visits13.7K
▲ 557.1% vs previous month
Similar companies to Saturn Formulations
10 companies that operate in the same segment as Saturn Formulations (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saturn Formulations
Saturn Formulations was founded in 2017.
Saturn Formulations is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Saturn Formulations, Saturn Formulations Private Limited, reported revenue of ₹10.09 Cr for FY 2024, up 10% year on year.
Saturn Formulations is a pharmaceutical company in India specializing in third-party manufacturing and PCD franchise services. They produce a wide range of products including tablets, injectables, and nutraceuticals across categories like gynaecology, dermatology, and orthopedics. Operating from facilities in Panchkula and Mumbai, they ensure high-quality standards with ISO and GMP certifications. Their services cater to healthcare providers and partners through reliable distribution and support.
Saturn Formulations offers Satlipa Eye Drop, Sat-D3 Nano Shot, Eropam A 1.5, Gisempa-10, and 2 more products and services.
Saturn Formulations operates through Saturn Formulations Private Limited.
The legal entities of Saturn Formulations currently have 2 directors, including Neeraj Sharda, Hans Raj Sharda.